{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:34:01Z","timestamp":1793046841209,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,2]],"date-time":"2027-06-02T00:00:00Z","timestamp":1811894400000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.contraception.2025.111015","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:12:06Z","timestamp":1752567126000},"page":"111015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Using updated clinical recommendations to support contraceptive decision-making: U.S. medical eligibility criteria for contraceptive use, 2024"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-3786","authenticated-orcid":false,"given":"Kathryn M.","family":"Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi K.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.111015_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.111015_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. selected practice recommendations for contraceptive use, 2024","volume":"73","author":"Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.111015_bib3","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111015_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.111015_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111015_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.15585\/mmwr.mm6914a3","article-title":"Update to U.S. medical eligibility criteria for contraceptive use, 2016: updated recommendations for the use of contraception among women at high risk for HIV infection","volume":"69","author":"Tepper","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.contraception.2025.111015_bib7","first-page":"Cd010813","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111015_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111015_bib9","first-page":"Cd011054","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"2015","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111015_bib10","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111015_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2015.04.021","article-title":"Current use of oral contraceptives and the risk of first-ever ischemic stroke: a meta-analysis of observational studies","volume":"136","author":"Xu","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2025.111015_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2025.111015_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","article-title":"Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives","volume":"89","author":"Dinger","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2005.08.005","article-title":"Combined oral contraceptive use among women with hypertension: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.contraception.2016.05.014","article-title":"Combined hormonal contraceptive use among obese women and risk for cardiovascular events: a systematic review","volume":"94","author":"Horton","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0010-7824(03)00073-8","article-title":"Oral contraceptives use and the risk of myocardial infarction: a meta-analysis","volume":"68","author":"Khader","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.111015_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/dc16-1534","article-title":"Hormonal contraception and risk of thromboembolism in women with diabetes","volume":"40","author":"O'Brien","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2025.111015_bib19","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/jth.13349","article-title":"Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis","volume":"14","author":"van Vlijmen","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.111015_bib20","article-title":"Progestin-only contraception and thrombosis: an updated systematic review","author":"Tepper","year":"2025","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.contraception.2025.111015_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111015_bib23","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/ndt\/gfq179","article-title":"Cushman M. Chronic kidney disease and venous thromboembolism: a prospective study","volume":"25","author":"Folsom","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.contraception.2025.111015_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjmed.2007.08.042","article-title":"Venous thromboembolism in patients hospitalized with nephrotic syndrome","volume":"121","author":"Kayali","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2025.111015_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2025.111015_bib26","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/ndt\/gfx212","article-title":"Risk and complications of venous thromboembolism in dialysis patients","volume":"33","author":"Molnar","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.contraception.2025.111015_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2025.111015_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1053\/ajkd.2002.32774","article-title":"Chronic dialysis patients have high risk for pulmonary embolism","volume":"39","author":"Tveit","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.contraception.2025.111015_bib29","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/ndt\/gfw272","article-title":"Risk of pulmonary embolism in patients with end-stage renal disease receiving long-term dialysis","volume":"32","author":"Wang","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.contraception.2025.111015_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1681\/ASN.2007030308","article-title":"Chronic kidney disease increases risk for venous thromboembolism","volume":"19","author":"Wattanakit","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.contraception.2025.111015_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","article-title":"The three-year incidence of fracture in chronic kidney disease","volume":"86","author":"Naylor","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.contraception.2025.111015_bib32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.contraception.2025.111015_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.ajkd.2020.02.450","article-title":"Risks of hip and nonvertebral fractures in patients with CKD G3a-G5D: a systematic review and meta-analysis","volume":"76","author":"Vilaca","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.contraception.2025.111015_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib35","doi-asserted-by":"crossref","unstructured":"Kortsmit K, Nguyen AT, Curtis KM, Burgner A, Folger SG, Whiteman MK. Safety and effectiveness of contraception among women with chronic kidney disease: a systematic review. Contraception: https:\/\/doi.org\/10.1016\/j.contraception.2025.111207","DOI":"10.1016\/j.contraception.2025.111207"},{"key":"10.1016\/j.contraception.2025.111015_bib36","unstructured":"Nguyen AT, Nandi P, Roe AH, H PL, Whiteman MK, Tepper NK, et al. Safety of hormonal contraception among women with sickle cell disease: an updated systematic review. Contraception: under review."},{"key":"10.1016\/j.contraception.2025.111015_bib37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ajh.25508","article-title":"High incidence of venous thromboembolism recurrence in patients with sickle cell disease","volume":"94","author":"Brunson","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.contraception.2025.111015_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14655","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality","volume":"178","author":"Brunson","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2025.111015_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033278","article-title":"Incidence and risk factors for new and recurrent infarcts in adults with sickle cell disease","volume":"13","author":"Jordan","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.contraception.2025.111015_bib40","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2016-01-694562","article-title":"Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia","volume":"127","author":"Kassim","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.111015_bib41","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/jth.12744","article-title":"Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease","volume":"12","author":"Naik","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.111015_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12959-018-0179-z","article-title":"Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis","volume":"16","author":"Noubiap","year":"2018","journal-title":"Thromb J"},{"key":"10.1016\/j.contraception.2025.111015_bib43","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.111015_bib44","unstructured":"Nguyen AT, Tepper NK, Gold H, Ramer S, Curtis KM, Whiteman MK. Safety of contraception among women using anticoagulant therapy: an updated systematic review. Contraception: under review."},{"key":"10.1016\/j.contraception.2025.111015_bib45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.111015_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.contraception.2010.02.007","article-title":"Contraceptive use among solid organ transplant patients: a systematic review","volume":"82","author":"Paulen","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib47","doi-asserted-by":"crossref","unstructured":"Baker CC, Suresh T, Nguyen AT, Curtis KM, Tepper NK, Whiteman MK. Safety and effectiveness of contraception among women with solid organ transplants: an updated systematic review. Contraception: https:\/\/doi.org\/10.1016\/j.contraception.2025.111205","DOI":"10.1016\/j.contraception.2025.111205"},{"key":"10.1016\/j.contraception.2025.111015_bib48","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.contraception.2011.05.012","article-title":"Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas","volume":"84","author":"Bahamondes","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib49","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.contraception.2016.11.008","article-title":"Use of the levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients: a case series","volume":"95","author":"Huguelet","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.contraception.2018.04.017","article-title":"A case series on the use of levonorgestrel 52\u00a0mg intrauterine system after organ transplant","volume":"98","author":"Juliato","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib51","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.contraception.2011.12.008","article-title":"Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review","volume":"86","author":"Ramhendar","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib52","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.contraception.2016.06.021","article-title":"Immunologic evaluation of the endometrium with a levonorgestrel intrauterine device in solid organ transplant women and healthy controls","volume":"94","author":"Kim","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.contraception.2016.06.011","article-title":"Safety of intrauterine devices among women with HIV: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib54","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2012.05.008","article-title":"Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"60","author":"Lentine","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2025.111015_bib55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12659\/AOT.882641","article-title":"Hypertension in solid organ transplant recipients","volume":"17","author":"Zbroch","year":"2012","journal-title":"Ann Transplant"},{"key":"10.1016\/j.contraception.2025.111015_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bone.2019.07.006","article-title":"Bone disease following solid organ transplantation: a narrative review and recommendations for management from The European Calcified Tissue Society","volume":"127","author":"Anastasilakis","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.contraception.2025.111015_bib57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11914-011-0083-y","article-title":"Osteoporosis after transplantation","volume":"10","author":"Kulak","year":"2012","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.contraception.2025.111015_bib58","article-title":"Safety of hormonal contraception among women with liver disease: an updated systematic review","author":"Kapp","year":"2025","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.contraception.2009.03.024","article-title":"Intrauterine device insertion during the postpartum period: a systematic review","volume":"80","author":"Kapp","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajog.2020.02.045","article-title":"Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and intrauterine device type: a systematic review and meta-analysis","volume":"223","author":"Averbach","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111015_bib61","unstructured":"Centers for Disease Control and Prevention. Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. 2024. \u3008https:\/\/stacks.cdc.gov\/view\/cdc\/156516\u3009 (accessed 2024)."},{"key":"10.1016\/j.contraception.2025.111015_bib62","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/AOG.0000000000002822","article-title":"Intrauterine device expulsion after postpartum placement: a systematic review and meta-analysis","volume":"132","author":"Jatlaoui","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111015_bib63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.contraception.2021.01.017","article-title":"Systemic hormonal contraception initiation after abortion: a systematic review and meta-analysis","volume":"103","author":"Kim","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib64","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/AOG.0000000000001627","article-title":"Effects of depot medroxyprogesterone acetate injection timing on medical abortion efficacy and repeat pregnancy: a randomized controlled trial","volume":"128","author":"Raymond","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111015_bib65","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/AOG.0000000000001274","article-title":"Effect of immediate compared with delayed insertion of etonogestrel implants on medical abortion efficacy and repeat pregnancy: a randomized controlled trial","volume":"127","author":"Raymond","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111015_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","volume":"130","author":"Stanczyk","year":"2024","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111015_bib67","doi-asserted-by":"crossref","unstructured":"Tepper NK, Curtis KM, Nguyen AT, Zapata LB, Cohen M, Whiteman MK. Research gaps in evidence-based contraception guidance: U.S. Medical Eligibility Criteria for Contraceptive Use, 2024, and U.S. Selected Practice Recommendations for Contraceptive Use, 2024. Contraception: https:\/\/doi.org\/10.1016\/j.contraception.2025.111209","DOI":"10.1016\/j.contraception.2025.111209"},{"key":"10.1016\/j.contraception.2025.111015_bib68","doi-asserted-by":"crossref","first-page":"739","DOI":"10.15585\/mmwr.mm7020a2","article-title":"Update to U.S. selected practice recommendations for contraceptive use: self-administration of subcutaneous depot medroxyprogesterone acetate","volume":"70","author":"Curtis","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.contraception.2025.111015_bib69","unstructured":"Centers for Disease Control and Prevention. U.S. MEC and U.S. SPR Provider Tools. 2024. \u3008https:\/\/www.cdc.gov\/contraception\/hcp\/provider-tools\/index.html\u3009 (accessed May 6, 2025)."},{"key":"10.1016\/j.contraception.2025.111015_bib70","unstructured":"App Store. Contraception, Centers for Disease Control and Prevention. \u3008https:\/\/apps.apple.com\/us\/app\/contraception\/id595752188?OCID=MY01SV&form=MY01SV\u3009 (accessed May 6, 2025)."},{"key":"10.1016\/j.contraception.2025.111015_bib71","unstructured":"Centers for Disease Control and Prevention. Contraception app. 2024. \u3008https:\/\/www.cdc.gov\/contraception\/hcp\/contraceptive-guidance\/app.html\u3009 (accessed May 6, 2025)."},{"key":"10.1016\/j.contraception.2025.111015_bib72","unstructured":"Google Play. Contraception, Centers for Disease Control and Prevention. 2025. \u3008https:\/\/play.google.com\/store\/apps\/details?id=gov.cdc.ondieh.nccdphp.contraception2&form=MY01SV&OCID=MY01SV\u3009 (accessed May 6, 2025)."},{"key":"10.1016\/j.contraception.2025.111015_bib73","unstructured":"American College of Obstetricians and Gynecologists. \u3008https:\/\/www.acog.org\/clinical\/clinical-guidance\/acog-endorsed\u3009 (accessed May 6, 2025)."},{"key":"10.1016\/j.contraception.2025.111015_bib74","unstructured":"North American Society for Pedatric and Adolescent Gynecology. \u3008https:\/\/www.naspag.org\/index.php?option=com_content&view=article&id=87:naspag-endorsed-documents&catid=20:site-content&Itemid=150\u3009 (accessed May 6, 2025)."},{"key":"10.1016\/j.contraception.2025.111015_bib75","unstructured":"Society for Maternal-Fetal Medicine. \u3008https:\/\/publications.smfm.org\/publications\/599-us-medical-eligibility-criteria-for-contraceptive-use-2024\/\u3009 (accessed May 6, 2025)."},{"key":"10.1016\/j.contraception.2025.111015_bib76","unstructured":"Society of Family Planning. \u3008https:\/\/societyfp.org\/clinical\/clinical-guidance-library\/\u3009 (accessed\u00a0May 6, 2025)."},{"key":"10.1016\/j.contraception.2025.111015_bib77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jclinepi.2017.08.009","article-title":"Living systematic reviews: 4. Living guideline recommendations","volume":"91","author":"Akl","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.111015_bib78","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2005.02.008","article-title":"Keeping up with evidence a new system for WHO's evidence-based family planning guidance","volume":"28","author":"Mohllajee","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2025.111015_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hex.12467","article-title":"Framework for enhancing clinical practice guidelines through continuous patient engagement","volume":"20","author":"Armstrong","year":"2017","journal-title":"Health Expect"},{"key":"10.1016\/j.contraception.2025.111015_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081903","article-title":"Core GRADE 1: overview of the Core GRADE approach","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111015_bib81","series-title":"Clinical Practice Guidelines We Can Trust","article-title":"Clinical practice guidelines we can trust","author":"Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"10.1016\/j.contraception.2025.111015_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13012-015-0205-5","article-title":"Developing a checklist for guideline implementation planning: review and synthesis of guideline development and implementation advice","volume":"10","author":"Gagliardi","year":"2015","journal-title":"Implement Sci"},{"key":"10.1016\/j.contraception.2025.111015_bib83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated consolidated framework for implementation research based on user feedback","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"key":"10.1016\/j.contraception.2025.111015_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12961-022-00815-4","article-title":"Strategies for the implementation of clinical practice guidelines in public health: an overview of systematic reviews","volume":"20","author":"Pereira","year":"2022","journal-title":"Health Res Policy Syst"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425002069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425002069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:17:03Z","timestamp":1780712223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425002069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":84,"alternative-id":["S0010782425002069"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111015","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using updated clinical recommendations to support contraceptive decision-making: U.S. medical eligibility criteria for contraceptive use, 2024","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111015"}}